Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
Annali Italiani Di Chirurgia
|
September 1, 1989
[Traumatic duodenal lesions]
G Teutonico, S Manfrini, G B Dalla Valle, et al.
Archives of Disease in Childhood
|
July 24, 2003
Environmental risk factors for type 1 diabetes in Rome and province
N Visalli, L Sebastiani, E Adorisio, et al.
Diabetes/Metabolism Research and Reviews
|
July 13, 2006
Raised C-reactive protein levels in patients with recent onset type 1 diabetes
A Picardi, M G Valorani, U Vespasiani Gentilucci, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
November 26, 2005
Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes
P Pozzilli, S Manfrini, A Crinò, et al.
Diabetes, Nutrition & Metabolism
|
December 6, 2000
Fibronectin and lipoprotein(a) are inversely related to plasminogen activator inhibitor type-1 levels in Type 2 diabetic patients without complications
R Testa, A R Bonfigli, C Sirolla, et al.
Minerva Chirurgica
|
September 30, 1985
[Retroperitoneal tumors. Clinical contribution]
G Teutonico, S Pollice, S Belcastro, et al.
Minerva Cardioangiologica
|
July 1, 1985
[Indications for and limits of lumbar sympathectomy in the treatment of chronic peripheral arteriosclerosis obliterans]
S Pollice, G Teutonico, G F Azzena, et al.
Diabetes, Nutrition & Metabolism
|
December 4, 2004
Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients
R Testa, A R Bonfigli, C Sirolla, et al.
Diabetes, Nutrition & Metabolism
|
April 27, 2000
A strong inverse relationship between PAI-1 and Lp(a) in hypertensive Type 2 diabetic patients
R Testa, A R Bonfigli, C Sirolla, et al.
Diabetes, Nutrition & Metabolism
|
June 1, 2001
Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patients
A R Bonfigli, C Pieri, S Manfrini, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
Annali Italiani Di Chirurgia
|
September 1, 1989
[Traumatic duodenal lesions]
G Teutonico, S Manfrini, G B Dalla Valle, et al.
Archives of Disease in Childhood
|
July 24, 2003
Environmental risk factors for type 1 diabetes in Rome and province
N Visalli, L Sebastiani, E Adorisio, et al.
Diabetes/Metabolism Research and Reviews
|
July 13, 2006
Raised C-reactive protein levels in patients with recent onset type 1 diabetes
A Picardi, M G Valorani, U Vespasiani Gentilucci, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
November 26, 2005
Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes
P Pozzilli, S Manfrini, A Crinò, et al.
Diabetes, Nutrition & Metabolism
|
December 6, 2000
Fibronectin and lipoprotein(a) are inversely related to plasminogen activator inhibitor type-1 levels in Type 2 diabetic patients without complications
R Testa, A R Bonfigli, C Sirolla, et al.
Minerva Chirurgica
|
September 30, 1985
[Retroperitoneal tumors. Clinical contribution]
G Teutonico, S Pollice, S Belcastro, et al.
Minerva Cardioangiologica
|
July 1, 1985
[Indications for and limits of lumbar sympathectomy in the treatment of chronic peripheral arteriosclerosis obliterans]
S Pollice, G Teutonico, G F Azzena, et al.
Diabetes, Nutrition & Metabolism
|
December 4, 2004
Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients
R Testa, A R Bonfigli, C Sirolla, et al.
Diabetes, Nutrition & Metabolism
|
April 27, 2000
A strong inverse relationship between PAI-1 and Lp(a) in hypertensive Type 2 diabetic patients
R Testa, A R Bonfigli, C Sirolla, et al.
Diabetes, Nutrition & Metabolism
|
June 1, 2001
Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patients
A R Bonfigli, C Pieri, S Manfrini, et al.
Page
of 6